These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31615002)

  • 1. Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses.
    Lin HY; Lee CL; Chiu PC; Niu DM; Tsai FJ; Hwu WL; Lin SJ; Lin JL; Chang TM; Chuang CK; Lin SP
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31615002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of growth dynamics in different types of MPS: an attempt to explain the causes.
    Różdżyńska-Świątkowska A; Zielińska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2022 Sep; 17(1):339. PubMed ID: 36064607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period.
    Lin HY; Chuang CK; Lee CL; Tu RY; Lo YT; Chiu PC; Niu DM; Fang YY; Chen TL; Tsai FJ; Hwu WL; Lin SJ; Chang TM; Lin SP
    Am J Med Genet A; 2018 Sep; 176(9):1799-1809. PubMed ID: 30070758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses.
    Lin HY; Chuang CK; Lee CL; Chen MR; Sung KT; Lin SM; Hou CJ; Niu DM; Chang TM; Hung CL; Lin SP
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of 111 cases with mucopolysaccharidosis ⅣA].
    Yi MN; Zhang HW; Gao XL; Wang Y; Han LS; Qiu WJ; Gu XF
    Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):503-508. PubMed ID: 37312460
    [No Abstract]   [Full Text] [Related]  

  • 6. Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy.
    Lin HY; Chen MR; Lee CL; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33374885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA.
    Lin HY; Chen MR; Lin SM; Hung CL; Niu DM; Chuang CK; Lin SP
    Orphanet J Rare Dis; 2018 Aug; 13(1):148. PubMed ID: 30157891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019).
    Lin HY; Lee CL; Chang CY; Chiu PC; Chien YH; Niu DM; Tsai FJ; Hwu WL; Lin SJ; Lin JL; Chao MC; Chang TM; Tsai WH; Wang TJ; Chuang CK; Lin SP
    Orphanet J Rare Dis; 2020 Nov; 15(1):314. PubMed ID: 33160388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional independence of Taiwanese patients with mucopolysaccharidoses.
    Lee CL; Lin HY; Chuang CK; Chiu HC; Tu RY; Huang YH; Hwu WL; Tsai FJ; Chiu PC; Niu DM; Chen YJ; Chao MC; Chang TM; Lin JL; Chang CY; Kao YC; Lin SP
    Mol Genet Genomic Med; 2019 Aug; 7(8):e790. PubMed ID: 31215158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic Findings of Mucopolysaccharidosis and Comparison with Bone Mineral Density: A Study from Southeastern Turkey.
    Ayaz E; Bozaci AE
    J Clin Densitom; 2022; 25(4):475-484. PubMed ID: 36100508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III).
    Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR
    Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
    Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
    Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis].
    Huang YL; Li SY; Zhao XY; Fan LP; Lin WC; Zhou ZH; Cheng J; Liu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):510-4. PubMed ID: 22809603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries.
    Solano VM; Mandujano CYC; Avila-Rejon CA; Espin VH; Montaño HPQ
    Mol Genet Metab Rep; 2021 Sep; 28():100769. PubMed ID: 34113545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Macrosomia or Large for Gestational Age Be Predictive of Mucopolysaccharidosis Type I, II and VI?
    Różdżyńska-Świątkowska A; Jurecka A; Żuber Z; Tylki-Szymańska A
    Pediatr Neonatol; 2016 Jun; 57(3):181-7. PubMed ID: 26522251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).
    de Ruijter J; Broere L; Mulder MF; van der Ploeg AT; Rubio-Gozalbo ME; Wortmann SB; Visser G; Wijburg FA
    J Inherit Metab Dis; 2014 May; 37(3):447-54. PubMed ID: 24173409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in maxillomandibular morphology among patients with mucopolysaccharidoses I, II, III, IV and VI: a retrospective MRI study.
    Koehne T; Köhn A; Friedrich RE; Kordes U; Schinke T; Muschol N; Kahl-Nieke B
    Clin Oral Investig; 2018 Apr; 22(3):1541-1549. PubMed ID: 29046964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.